Search

everythinglearnresearchcommunity

for

Search:↓

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Finasteride effectively prevents biofilm formation and treats preformed biofilms, but requires high doses.

Tofacitinib helps hair regrow in some kids with severe alopecia areata, but more research is needed on long-term effects.

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

Combining doxazosin and finasteride is more effective for managing benign prostatic hyperplasia than using either drug alone.

JAK inhibitors help regrow hair in alopecia areata, but their long-term safety is still unclear.

Antifungal treatment reduced asthma exacerbations and corticosteroid use but its overall benefit is unclear.

New niosomal formulation effectively delivers aminexil through rat skin.

Cepharanthine is safe but not clearly effective in speeding up COVID-19 recovery.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

The paper concludes that the new medication baricitinib needs further testing in a more diverse group of patients with alopecia areata.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Tofacitinib is safe and effective for treating moderate-to-severe alopecia areata.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

5α-reductase inhibitors effectively treat enlarged prostate and hair loss but require careful use due to possible side effects.

Topical tofacitinib is effective and safe for treating alopecia areata.

Tofacitinib may help hair regrowth in alopecia areata, but more research is needed.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

A man with severe hair loss saw hair and nail improvement after 10 months on tofacitinib without side effects.

Nivolumab can cause hair loss as a rare side effect.

Tofacitinib might be used to treat hair loss.

Dutasteride's effect on hair loss treatment is uncertain and should be used cautiously.

cp-asiAR may effectively treat hair loss by targeting androgen receptors.

Itraconazole effectively treated a woman's painful skin condition and hair loss.